Lilly and Sigilon Therapeutics to develop encapsulated cell therapy for type 1 diabetes
Thursday, July 5, 2018 - 18:23
in Health & Medicine
Sigilon’s polymer encapsulation is based on the research of MIT scientists Daniel Anderson and Robert Langer